MedPath

on-invasive method for evaluating the development of interstitial structure and cancer malignancy using contrast-enhanced ultrasonography using Sonazoid

Not Applicable
Conditions
1. malignant tumor in the liver 2. chronic liver disease
Registration Number
JPRN-UMIN000011330
Lead Sponsor
Osaka City University Graduate School of Medicine Department of Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with a history of hypersensitivity to drug test Patients who are allergic to egg products or egg Patient nursing and pregnancy Patients attending physician has determined is inappropriate participation in this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath